Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years

被引:0
|
作者
Cappellini, M. Domenica [1 ]
Perrotta, Silverio [2 ]
Agaoglu, Leyla [3 ]
Aydinok, Yesim [4 ]
Capra, Marcello [5 ]
Canatan, Duran [6 ]
Drelichman, Guillermo [7 ]
Kilinc, Yurdanur [8 ]
Magnano, Carmelo [9 ]
Porter, John B. [10 ]
Piga, Antonio [11 ]
Griffel, Louis [12 ]
Lagrone, Darlene [12 ]
Clark, Joan [13 ]
Kattamis, Antonis [14 ]
机构
[1] Univ Milan, Fdn IRCCS Osped Maggiore Policlin Mangiagalli & R, Milan, Italy
[2] I Policlin II Univ Napoli, Naples, Italy
[3] Istanbul Univ, Istanbul Sch Med, Div Pediat Hematol Oncol, Istanbul, Turkey
[4] Ege Univ, Fac Med, Izmir, Turkey
[5] Osped Civ & Benefratelli G Di Cristina M Ascoli, Palermo, Italy
[6] Suleyman Demirel Univ, Fac Med, TR-32200 Isparta, Turkey
[7] Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina
[8] Cukurova Univ, Fac Med, Dept Pediat Hem Onc, Adana, Turkey
[9] Az Osped Riliervo Nazl & Alta Spec Garibaldi, Catania, Italy
[10] UCL, London, England
[11] Univ Turin, Turin, Italy
[12] Novartis Pharmaceut, E Hanover, NJ USA
[13] Novartis Pharma AG, Basel, Switzerland
[14] Univ Athens, Dept Pediat 1, Athens, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1558 / 1559
页数:2
相关论文
共 50 条
  • [21] Efficacy and Safety of Deferasirox in β-Thalassemia Major Patients in Iran: A Prospective Study from a Single referral Center in Iran
    Alavi, Samin
    Ebadi, Maryam
    Ghazizadeh, Farid
    Arzanian, Mohammad Taghi
    Shamsian, Bibishahin
    Gorji, Fatemeh Abdollah
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (01) : 76 - 86
  • [22] Exjade® (Deferasirox): Iron in Balance - Therapy Management in MDS- and Thalassemia-Patients
    Meyer, Ina
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02)
  • [23] Improvement in Liver Pathology of Patients With β-Thalassemia Treated With Deferasirox for at Least 3 Years
    Deugnier, Yves
    Turlin, Bruno
    Ropert, Martine
    Cappellini, M. Domenica
    Porter, John B.
    Giannone, Vanessa
    Zhang, Yiyun
    Griffel, Louis
    Brissot, Pierre
    GASTROENTEROLOGY, 2011, 141 (04) : 1202 - U618
  • [24] Relative Trends in Myocardial T2*Versus Myocardial Iron Concentration As Representations of Myocardial Iron Chelation Efficacy in Patients with β Thalassemia Major Treated with Deferasirox for up to 3 Years
    Porter, John B.
    Taher, Ali T.
    Aydinok, Yesim
    El-Beshlawy, Amal
    Elalfy, Mohsen
    El-Ali, Ali
    Barbier, Nathalie
    Cappellini, M. Domenica
    BLOOD, 2014, 124 (21)
  • [25] Efficacy and Safety of Deferasirox (Exjade®) in Preventing Cardiac Iron Overload in β-Thalassemia Patients with Normal Baseline Cardiac Iron: Results from the Cardiac Substudy of the EPIC Trial
    Pennell, Dudley
    Sutcharitchan, Prance
    El-Beshlawy, Amal
    Aydinok, Yesim
    Taher, Ali
    Smith, Gillian
    Habr, Dany
    Kriemler-Krahn, Ulrike
    Hmissi, Abdel
    Porter, John B.
    BLOOD, 2008, 112 (11) : 1318 - 1319
  • [26] Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major
    Vlachaki, Efthymia
    Agapidou, Alexandra
    Spanos, Georgios
    Klonizakis, Philippos
    Vetsiou, Evaggelia
    Mavroudi, Melahrini
    Boura, Panagiota
    HEMOGLOBIN, 2015, 39 (05) : 299 - 304
  • [27] EFFICACY AND SAFETY WITH DEFERASIROX (EXJADE®), A ONCE-DAILY ORAL CHELATOR IN THALASSEMIC ADULTS
    Vlachaki, V. E.
    Haralambidou, S. H.
    Perifanis, V. P.
    Spanos, G. S.
    Tsatra, I. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 463 - 463
  • [28] Deferasirox in Indian children with thalassemia major: 3 years experience
    Dhamija, Mayank
    Mahajan, Amita
    Kalra, Manas
    Virmani, Anju
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (01) : 16 - 20
  • [29] Efficacy and safety of thalidomide in patients with β-thalassemia intermedia and major
    Ju, Wendong
    Din, Gaomin
    Huang, Jun
    Zheng, Minmin
    Wang, Xiaoyou
    Liu, Lingling
    Wang, Li
    Xuan, Suling
    Xiao, Weiqun
    Chen, Ang
    MEDICINE, 2024, 103 (43)
  • [30] A 5-Years Follow-up in Deferasirox Treatment: Improvement of Cardiac and Hepatic Iron Overload and Amelioration in Cardiac Function in Thalassemia Major Patients
    Cassinerio, Elena
    Roghi, Alberto
    Orofino, Nicola
    Pedrotti, Patrizia
    Zanaboni, Laura
    Poggiali, Erika
    Giuditta, Marianna
    Consonni, Dario
    Cappellini, Maria Domenica
    BLOOD, 2014, 124 (21)